SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000897069-04-001279
Filing Date
2004-07-08
Accepted
2004-07-08 12:02:47
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STMT. sdc760.htm S-3 179153
2 STOCK PURCHASE AGREEMENT sdc760a.htm EX-4.3 119700
3 REGISTRATION RIGHTS AGREEMENT sdc760b.htm EX-4.4 113861
4 OPINION OF COUNSEL sdc760c.htm EX-5.1 4382
5 CONSENT OF KPMG LLP sdc760d.htm EX-23.1 1734
  Complete submission text file 0000897069-04-001279.txt   420681
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-117219 | Film No.: 04905588
SIC: 2836 Biological Products, (No Diagnostic Substances)